6
AMINOGLYCOSIDES.: Aminoglycosides that are derived from bacteria of the Streptomyces genus are named with the suffix mycin, whereas those that are derived from Micromonospora are named with the suffix micin. CHEMICAL STRUCTURE: The aminoglycosides consist of two or more amino sugars joined in glycosidic linkage to an hexose nucleus. Different aminoglycosides are distinguished by the amino sugars attached to the aminocyclitol. Streptomycin differs from the other aminoglycoside antibiotics in that it contains streptidine rather than 2-deoxystreptamine, and the aminocyclitol is not in a central position. MECHANISM OF ACTION: Aminoglycosides action include a large variety of antibiotic mechanisms, some as protein synthesis inhibitors.they Interfere with the proofreading process, in turn, increasing the rate of error in premature termination synthesis. SPECTRUM OF ACTIVITY: These antibiotics are most often used to treat infections involving aerobic, gram-negative bacteria, such as Acinetobacter, Pseudomonas, and Enterobacter. In some cases, certain microbacteria, like the bacteria responsible for causing tuberculosis, are vulnerable to this type of antibiotic. Aminoglycosides are most often used as empiric therapy for serious infections, including complicated intra-abdominal infections, nosocomial respiratory tract infections, septicemia, and complicated urinary tract infections. This type of antibiotic is mostly unable to treat fungi, anaerobic bacteria, and viruses. GENTAMYCIN AS AN ANTIBIOFILM. COMMONLY USED BRAND NAME(S): (1)Alcomicin(2) Garamycin(3)Genoptic Liquifilm(4) Genoptic S.O.P.(5) Gentacidin(6) Gentafair(7) Gentak(8) Ocu-Mycin(9) Spectro-Genta. STRUCTUREOF GENTAMYCIN :

Gentamycin as an Antibiofilm

  • Upload
    maha

  • View
    17

  • Download
    0

Embed Size (px)

DESCRIPTION

gentamicin

Citation preview

AMINOGLYCOSIDES.:Aminoglycosides that are derived from bacteria of the Streptomyces genus are named with the sufx mycin, whereas those that are derived from Micromonospora are named with the sufx micin. CHEMICAL STRUCTURE:The aminoglycosides consist of two or more amino sugars joined in glycosidic linkage to an hexose nucleus. Diferent aminoglycosides are distinguished by the amino sugars attached to the aminocyclitol. tre!tomycin difers from the other aminoglycoside antibiotics in that it contains stre!tidine rather than "#deoxystre!tamine, and the aminocyclitol is not in a central !osition.MECHANISM OF ACTION:Aminoglycosides action include a large variety of antibiotic mechanisms, some as !rotein synthesis inhibitors.they $nterfere with the !roofreading !rocess, in turn, increasing the rate of error in !remature termination synthesis.SPECTRUM OF ACTIVITY:These antibiotics are most often used to treat infections involving aerobic, gram#negative bacteria, such as Acinetobacter, Pseudomonas, and Enterobacter. $n some cases, certain microbacteria, like the bacteria res!onsible for causing tuberculosis, are vulnerable to this ty!e of antibiotic. Aminoglycosides are most often used as em!iric thera!y for serious infections, including com!licated intra#abdominal infections, nosocomial res!iratory tract infections, se!ticemia, and com!licated urinary tract infections. This ty!e of antibiotic is mostly unable to treat fungi, anaerobic bacteria, and viruses.%&'TA()*$' A A' A'T$+$,-$.(.COMMONLY USED BRAND NAME(S): /01Alcomicin(2) Garamycin(3)Genoptic Liquiflm(4) Genoptic S!P(") Gentacidin(#)Genta$air(%) Genta&(') !cu(Mycin()) Spectro(GentaSTRUCTUREOF GENTAMYCIN : CHEMICAL GROUPaminoglycosides CHITOSAN WITH GENTAMICIN AGAINST LISTERIA SPECIES2014: http://www.nc!.n"#.n!h.$%&/p#c/'(t!c")*/PMC42+4,0+/INTRODUCTION:Chitosan is the N-deacetylated derivative of chitin, a naturally abundant mucopolysaccharide consisting of 2-acetamido-2-deoxy-co-d-glucose. chitosan exhibits anti-biofilm activities and the ability of chitosan to damagebiofilms formed by microbes has been documented. Previously, we have reported a synergistic effect betweenstreptomycin and chitosan on the disruption of Listeria monocytogenes biofilmsWe found that chitosan couldimprove anti-biofilm efficacy of gentamicin belonging to the aminoglycoside family against Listeria biofilmsDISPERSIN-. GENTAMYCIN COM.INATION AGAINST MRSP2014:http://www.nc!.n"#.n!h.$%&/p/#)0/2441101,INTRODUCTION:Our study assesses the applicability of a new microfluidic model by testing the activity of ispersin! againstbiofilms of methicillin-resistant "taphylococcus pseudintermedius #$%"P&' ispersin! has been shown toprevent biofilm growth of "taphylococcus epidermidis, another prominent wound coloni(er.METHOD: )n the microtitre plate assay, ispersin! inhibited biofilm growth after a 2* hour period' there wasan inverse relationship between the concentration of ispersin!-+entamycin and the amount of biofilmremaining following treatment. Collagen-coated microtitre plates showed a similar result, but this did notcorrelate as well' collagen, the most abundant protein in the body may help to retain the biomass of treatedbiofilms.GENTAMYCIN AGAINST 1PC-PROD2CING 1.PNE2MONIAE2014: http://www.nc!.n"#.n!h.$%&/p/#)0/2440+3++,+2&*T$3&4,PC-producing ,lebsiella pneumoniae #,PC-,pn& is a worldwide challenging pathogen, yet its biofilm-formingpotential is not defined. We characteri(ed biofilm formation of this pathogen and determined biofilm susceptibilityto gentamicin and colistin.(&T5,D4-orty-six ,PC-,pn clinical isolates were studied .se/uence type #"0& 212, n 3 22' and other "0s, n 3 425. !iofilmbiomass was determined using the standard assay measured by O167 #where O stands for optical density& andvisuali(ed using confocal microscopy. 8ntibiotic effect on biofilm formation was evaluated and susceptibility withinbiofilm was determined by the minimal biofilm elimination concentration #$!9C& method.GENTAMYCIN WITH L-ARGININE:20144 htt!466www.ncbi.nlm.nih.gov6!ubmed6"789:7;"BACKGROUND::imitations in treatment of biofilm-associated bacterial infections are often due to subpopulation of persistentbacteria #persisters& tolerant to high concentrations of antibiotics. !ased on the increased aminoglycoside efficiencyunder al;aline conditions, we studied the combination of gentamicin and the clinically compatible basic amino acid:-arginine against plan;tonic and biofilm bacteria both in vitro and in vivo.METHODS: